Analyst Praises AMD-Partner Absci's Practical Approach, Sees 118% Stock Upside
Needham initiated a Buy rating for Absci (ABSI), noting its AI-powered drug discovery platforms, strategic partnerships, and ...
AMD stock touches 52-week low at $114.41 amid market shifts
Advanced Micro Devices, Inc. (NASDAQ:AMD) stock has reached a 52-week low, dipping to $114.41, as investors navigate a challenging market environment. According to InvestingPro data, the company ...
Hosted on MSN20d
AMD Invests in Drug-Discovery Company Absci in Push to Sell AI Chips
The deal is structured as a private investment in a public equity and includes an equity stake in Absci. AMD didn’t disclose the amount of its stake. AMD, which is based in Santa Clara ...
Seeking Alpha15d
Absci Looks Cheap And Positioned For Growth With AMD's AI Backing
Absci recently received a $20 million PIPE investment from AMD that improves its runway and R&D platform with AI. ABS-101 appears to be ABSI’s main drug candidate for IBD. However, ABS-201 for ...
Yahoo Finance20d
Absci Stock Jumps As AMD Invests $20M To Boost AI Drug Discovery
The partnership will leverage AMD Instinct accelerators and ROCm software to support Absci’s advanced de novo antibody design models. The deal also includes a $20 million private investment in ...
Absci shares jump as analyst lauds 'practical' AI drug company
"In our view, the ability to generate high quality wet-lab data is critical for advancement," analyst says in initiating ...
Eagle-Tribune20d
Absci and AMD Announce Collaboration and Strategic Investment to Accelerate the Future of AI ...
Jan. 08, 2025 (GLOBE NEWSWIRE) -- Absci Corporation (NASDAQ: ABSI), a data-first generative AI drug creation company, today announced a strategic collaboration with AMD to deploy AMD Instinct ...
MarketWatch20d
AMD is going head-to-head with Nvidia in AI-backed drug discovery with new deal
Advanced Micro Devices Inc. is going head-to-head with bigger rival Nvidia Corp. in artificial intelligence-backed drug discovery with news of a new partnership and investment in startup Absci ...
AbSci (ABSI) Gets a Buy from Truist Financial
Truist Financial analyst Srikripa Devarakonda assigned a Buy rating to the stock today. The company’s shares closed last Friday at $2.90.Invest ...
Yahoo Finance18d
Advanced Micro Devices (AMD) Invests in Absci for AI-Driven Drug Discovery with High-Performance Computing Solutions
In this article, we are going to take a look at where Advanced Micro Devices, Inc. (NASDAQ:AMD) stands against other AI stocks. As per a CNBC report, in 2025, significant changes are expected in ...
AbSci’s Strategic Partnerships and Strong Financial Position Justify Buy Rating
Swayampakula Ramakanth, an analyst from H.C. Wainwright, maintained the Buy rating on AbSci (ABSI – Research Report). The associated price ...
Wall Street Journal20d
AMD Invests in Drug-Discovery Company Absci in Push to Sell AI Chips
The deal is structured as a private investment in a public equity and includes an equity stake in Absci. AMD didn’t disclose the amount of its stake.